scispace - formally typeset
M

Mourad Kaghad

Researcher at French Institute of Health and Medical Research

Publications -  49
Citations -  13336

Mourad Kaghad is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Peptide sequence & Complementary DNA. The author has an hindex of 33, co-authored 49 publications receiving 12973 citations.

Papers
More filters
Journal ArticleDOI

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

TL;DR: It is reported that mice homozygous for a disrupted p63 gene have major defects in their limb, craniofacial and epithelial development, and results indicate that p63 is critical for maintaining the progenitor-cell populations that are necessary to sustain epithelialDevelopment and morphogenesis.
Journal ArticleDOI

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

TL;DR: The cloning of p63, a gene at chromosome 3q27-29 that bears strong homology to the tumor suppressor p53 and to the related gene, p73, is described and the possibility of physiological interactions among members of the p53 family is suggested.
Journal ArticleDOI

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

TL;DR: The demonstration that p73 is monoallelically expressed supports the notion that it is a candidate gene in neuroblastoma and proposes that the disregulation of p73 contributes to tumorigenesis and that p53-related proteins operate in a network of developmental and cell cycle controls.
Journal ArticleDOI

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

TL;DR: It is shown that mice functionally deficient for all p73 isoforms exhibit profound defects, including hippocampal dysgenesis, hydrocephalus, chronic infections and inflammation, as well as abnormalities in pheromone sensory pathways, and there is a marked divergence in the physiological functions of the p53 family members.
Journal ArticleDOI

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.

TL;DR: Recombinant IL-13 protein inhibits inflammatory cytokine production induced by lipopolysaccharide in human peripheral blood monocytes, and synergizes with IL-2 in regulating interferon-γ synthesis in large granular lymphocytes.